Recent Posts
- DiaCarta Enters a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to Develop Cancer Tests based on its Novel XNA Technology
- Diagnostic Developers Pursue SARS-CoV-2 Omicron Assays for Surveillance, Potential Clinical Use
- DiaCarta’s Multivariant COVID-19 Test Accurately Detects the Omicron Variant
- Early Cancer Detection Will Save More Lives
- Assay Detects Precancerous Colorectal Cancer Lesions & Mutations
Archives
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- May 2021
- April 2021
- November 2020
- October 2020
- September 2020
- July 2020
- April 2020
- March 2020
- August 2019
- April 2019
- January 2019
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- February 2018
- October 2017
- July 2017
- February 2017
- October 2016
- September 2016
- April 2016
- March 2016
- April 2015
- January 2015
- February 2014
- October 2013
Categories
- About
- Technology
- Products
- COVID-19 Total Solution
- QClamp® Gene Mutation Detection Tests
- ColoScape™ Colorectal Cancer Mutation Detection Test
- QuantiVirus™ HPV E6/E7 mRNA Test
- Direct Human DNA Quantification
- CRISPR-Quest Gene Editing Test
- Dimerator™ Adapter Dimer Removal
- VznHealth™ Benchtop Luminometer
- Thermo Shaker Incubator
- QFusion™ EML4-ALK and KIF5B-ALK Fusion Gene Detection Kit
- Services
- Resources
- COVID-19 Testing Service
Recent Comments